NEW YORK (GenomeWeb) – Ambry Genetics announced this week that it has opened its AmbryShare data sharing program to the public. AmbryShare contains data on more than 1 million variants from 11,400 hereditary breast and ovarian cancer patients. It is comprised of de-identified aggregated allele frequency data that includes analysis of all genes in the human genome. The company is also soliciting collaborations with interested researchers for new AmbryShare exome projects on autism and prostate cancer.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.